Pharmalot… Pharmalittle… The Weekend Nears

And so, another working week is about to draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. Our agenda is filled with chores and paperwork, but we do hope to spend time with the short people and catch up on some napping. As for you, anything special planned? You could do something novel, pun intended, and visit your local library, while it still exists. Or hang with a favorite person. And of course, there is always that big football game. Whatever you do, have a grand time, but be safe. See you soon… Merck Delays Filing Of Osteoperosis Drug (Reuters) UK’s NICE Rejects Avastin For Ovarian Cancer (Bloomberg News) Medicare To Adjust Payments For Dialysis Drugs (Washington Post) Pfizer’s Zoetis Raises $2.24 Billion In IPO (Bloomberg News) Search For A Tuberculosis Vaccine May Pay Off (Reuters) Bristol-Myers To Sell Consumer Brands In Mexico And Brazil (Dow Jones) Celsion Shares Hit By Liver Cancer Drug Failure (Pharma Times) EDITOR’S NOTE: Please check this post for additional items during the day couch pic thx to ejegustafsson on flickr
Source: Pharmalot - Category: Pharma Commentators Authors: Tags: Uncategorized Amgen Avastin Bristol-Myres Squibb Celsion Dialysis IPO Liver Cancer Medicare Merck Overian Cancer Pfizer Roche TB Tuberculosis Vaccines Zoetis Source Type: blogs